NM_139276.3:c.1261G>A
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_139276.3(STAT3):c.1261G>A(p.Gly421Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_139276.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152226Hom.: 0 Cov.: 32 FAILED QC
GnomAD4 exome Cov.: 32
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
STAT3-related early-onset multisystem autoimmune disease Pathogenic:1
segregates with the phenotype in an affected family -
not provided Pathogenic:1
The G421R variant has been published previously in association with STAT3-related disorders (Milner et al., 2015; Khoury et al., 2017). The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). G421R is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. In summary, we consider this variant to be likely pathogenic. -
STAT3-related disorder Pathogenic:1
This variant has been previously reported as a heterozygous change in patients with Early-onset lymphoproliferation and autoimmunity, Immune dysregulation and Evans syndrome (PMID: 25359994, 30092289, 30940614). Flow cytometry analysis of peripheral blood mononuclear cells from a patient showed delayed phosphorylation compared with healthy controls (PMID: 25359994). It is absent from the gnomAD population database and thus is presumed to be rare. The c.1261G>A (p.Gly421Arg) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.1261G>A (p.Gly421Arg) variant is classified as Likely Pathogenic. -
Hyper-IgE recurrent infection syndrome 1, autosomal dominant Pathogenic:1
Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with supporting evidence (ClinVar ID: VCV000224844.3, PMID: 30940614 and 25359994, PS1_P). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.653, 3Cnet: 0.951, PP3). Therefore, this variant is classified as likely pathogenic according to th recommendation of ACMG/AMP guideline. -
Hyper-IgE recurrent infection syndrome 1, autosomal dominant;C4288261:STAT3 gain of function Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects STAT3 function (PMID: 25359994). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt STAT3 protein function. ClinVar contains an entry for this variant (Variation ID: 224844). This missense change has been observed in individual(s) with clinical features of STAT3 gain of function associated autoimmune disease and/or Evans syndrome (PMID: 25359994, 30940614, 32531373, 32944025). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 421 of the STAT3 protein (p.Gly421Arg). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at